Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 11, 2026
CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World Setting.
Journal: Transplantation and cellular therapy
Published: August 27, 2025
Validation of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in patients with multiple myeloma who were enrolled in the CARTITUDE-4 trial.
Journal: Journal of patient-reported outcomes
Published: July 23, 2025
Weekly dosing schedule of brentuximab vedotin is well tolerated in mycosis fungoides/Sézary syndrome.
Journal: British journal of haematology
Published: May 13, 2025
A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL.
Journal: Blood advances
Published: May 13, 2025
Nivolumab plus ifosfamide, carboplatin, and etoposide are a highly effective first salvage regimen in high-risk relapsed/refractory Hodgkin lymphoma.
Journal: HemaSphere
Published: December 17, 2024
Impact of memory T cells on SARS-CoV-2 vaccine response in hematopoietic stem cell transplant.
Journal: PloS one
Published: October 29, 2024
Real World Data on Efficacy and Safety of EPOCH in T-Cell Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 26, 2024
Patient-reported outcomes following ciltacabtagene autoleucel or standard of care in patients with lenalidomide-refractory multiple myeloma (CARTITUDE-4): results from a randomised, open-label, phase 3 trial.
Journal: The Lancet. Haematology
Published: May 08, 2024
Addressing platelet insecurity - A national call to action.
Journal: Transfusion
Published: May 06, 2024
Last Updated: 09/26/2026